Bioequivalence

As per available reports about 38 journals, 21 Conferences and 14 Workshops are presently dedicated exclusively to Bioequivalence and about 382 articles are being published on the current trends in Bioequivalence . In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to bioequivalence are being carried out. As reported in above mentioned article, Bioequivalence is a term in pharmacokinetics used to assess the expected in vivo biological equivalence of two proprietary preparations of a drug. If two products are said to be bioequivalent it means that they would be expected to be, for all intents and purposes, the same.

The Journal of Bioequivalence & Bioavailability is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Bioequivalence . Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Bioequivalence & Bioavailability provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Bioequivalence and Bioavailability, thus bridging the gap between researchers and young scientists.

OMICS International cordially invites all the participants across the globe to attend the 7^th World Congress on Bioavailabity & Bioequivalence: BA/BE Studies Summit during Aug 29 - Aug 31, 2016 at Atlanta, USA. Bioavailability and bioequivalence World Congress 2016 is a platform for various people from pharmaceutical backgrounds, HealthCare institutions, Pharmaceutical regulatory agencies, Biotech and Clinical Research organizations. The main theme of the World Congress meeting is “Innovative Approaches of BA/BE to Revolutionize the Next Generation Medicine”. We make sure that scientists and researchers get the popularity and rewards that they be and also the chance to play a big role within the international scientific community.